Table 3 Incidence rates and risks of AVF/AVG dysfunction in SLE and non-SLE patients.

From: Long-term prognosis of vascular access in hemodialysis patients with systemic lupus erythematosus: a retrospective cohort study

Vascular access type

SLE patients

Non-SLE patients (reference)

Crude

Competing risk

No. of Events

Person-years

Incidence ratea

No. of Events

Person-years

Incidence ratea

HR (95% CI)

P

SHR (95% CI)

P

AVF

780

33,724.2

20.94

2173

11,393.9

19.07

1.09 (1.00, 1.18)

0.045

1.10 (1.01–1.19)

0.022

AVG

144

202.7

71.06

416

556.3

74.78

0.94 (0.78, 1.14)

0.540

1.00 (0.83–1.20)

0.992

  1. AVF arteriovenous fistula, AVG arteriovenous graft, SLE systemic lupus erythematosus, HR hazard ratio, SHR subdistribution hazard ratio, CI confidence interval.
  2. aPer 100 person-years.